Story at a glance

  • The New York Times reports the Food and Drug Administration is expected to expand its emergency use authorization for the two-dose vaccine to adolescents ages 12 to 15 next week.
  • In late March, Pfizer and BioNTech announced their vaccine showed to be 100 percent effective and well tolerated in a clinical trial involving 2,260 participants ages 12 to 15.
  • The approval could result in many adolescents receiving a vaccination before the beginning of the next school year.

The Pfizer-BioNTech COVID-19 vaccine could soon get approval for use among adolescents, according to a new report. 

The New York Times reports the Food and Drug Administration (FDA) is expected to expand its emergency use authorization for the two-dose vaccine to adolescents ages 12 to 15 by next week, or perhaps even sooner. The outlet cited a federal health official with knowledge on the health agency’s plans. 


Our country is in a historic fight against the Coronavirus. Add Changing America to your Facebook or Twitter feed to stay on top of the news.


Following approval from the FDA, the Centers for Disease Control and Prevention’s (CDC) vaccine advisory panel will likely meet to review clinical trial data and develop recommendations for the use of the shot among children in that age group. 

In late March, Pfizer and BioNTech announced their vaccine showed to be 100 percent effective and well tolerated in a clinical trial involving 2,260 participants ages 12 to 15. The vaccine is currently authorized in the U.S. for emergency use in those 16 and older. 

The approval could result in many adolescents receiving a vaccination before the beginning of the next school year. 

The Times reports Moderna is also expecting results from a clinical trial involving those ages 12 to 17, with results for kids 6 months to 12 years old later in the year. 

Last week, BioNTech’s co-founder and chief medical officer Ozlem Tureci said data on how effective the shot is in children ages 5 to 11 could be released by the end of summer, and young children could begin getting vaccinated by the end of this year.


READ MORE STORIES FROM CHANGING AMERICA

COVID-RECOVERED PEOPLE MAY ONLY NEED ONE DOSE OF PFIZER OR MODERNA VACCINES

CDC GIVES NEW MASK GUIDANCE FOR OUTDOORS AND INDOORS

CDC INVESTIGATING NEW REPORTS OF BLOOD CLOT CASES LINKED TO J&J VACCINE

SOME US VACCINATION SITES ARE SHUTTING DOWN BECAUSE UNVACCINATED PEOPLE AREN’T WILLING TO GET THEIR SHOTS

PFIZER-BIONTECH BOOSTER LIKELY NEEDED AS IMMUNITY WANES, SAYS SCIENTIST WHO HELPED DEVELOP VACCINE


 

Published on May 04, 2021